PharmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin)...
progression
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may...
Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new...
Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular ‘map’ of...
Researchers have discovered that eliminating cells thought to aid tumor growth did not slow or halt the...
It may be possible to identify those patients at high risk of rapid disease progression upon relapse...
Biomarkers – surrogates which can be objectively measured and used as indicators for certain biological states, salutogenetic...
New research on the treatment of gastrointestinal cancers was released in advance of the seventh annual Gastrointestinal...